Clinical course and CSF amyloid β protein precursor having the site of application of the protease inhibitor (APPI) levels in patients with dementia of the Alzheimer type [1]
- K. Urakami
- , K. Takahashi
- , A. Okada
- , T. Oshima
- , Y. Adachi
- , S. Nakamura
- , N. Kitaguchi
- , Y. Tokushima
- , S. Yamamoto
- , S. Tanaka
Research output: Contribution to journal › Letter › peer-review
5
Link opens in a new tab
Citations
(Scopus)